Virtus Health Limited (VRT) - Research

$4.430 0.1 (2.21%)

VRT General Information +

ASX Code VRT
Website http://www.virtushealth.com.au
GICS Sub-Industry Health Care Facilities
Market Cap ($M) 356
Current Price $4.430
Day High $4.550
Day Low $4.410
Last Close $4.530
Price Movement $0.10 ( 2.21% )
Prices as at 12:15, 19 Jun 2019
+Security prices are delayed by at least 20 minutes and are indicative only.

Recommendation


Virtus Health Limited (VRT)
BUY
below
HOLD
up to
SELL
above
Current Price
$4.430 as at 12:15, 19 Jun 2019

Price at review
$4.430 on 08 Jun 19

Max Portfolio Weighting

Business Risk

Share Price Risk

VRT Related Research

VRT Company Overview

Business Description

Virtus Health Limited (VRT) is a healthcare services company which provides a variety of Assisted Reproductive Services, Specialised Diagnostics and Day Hospitals cross the eastern states of Australia. Virtus provide these services to its patients through a network of fertility clinics, embryology laboratories, andrology laboratories, specialised diagnostic testing laboratories and day hospitals.

VRT Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2018 A 33.04 39.30 1.20% 14.00 26.00 4.70% 100.0%
2017 A 33.22 38.80 -7.50% 16.60 25.00 3.90% 100.0%
2016 A 35.75 41.90 5.60% 14.40 29.00 4.80% 100.0%

VRT Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2016 A 2017 A 2018 A 2016 A 2017 A 2018 A 2016 A 2017 A 2018 A
Estia Health (EHE) $698M -0.0571 -0.1597 0.0055 15.6177 18.5853 18.4828 5.90% 5.27% 5.43%
Japara Healthcare (JHC) $345M -0.3578 0.0042 -0.1012 17.9666 17.8918 19.9074 6.01% 5.27% 5.04%
Regis Healthcare (REG) $770M -0.0739 -0.1569 -0.1159 13.5235 16.0401 18.1432 7.00% 6.07% 5.16%
Ramsay Health Care (RHC) $14,453M 0.0751 0.1477 0.1244 28.2275 24.5942 21.8722 2.01% 2.10% 2.35%
Virtus Health (VRT) $360M 0.0124 0.0000 0.0000 11.4140 0.0000 0.0000 5.80% 0.00% 0.00%

VRT Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.00 11.50 1.33 0.00
Market 0.88 17.10 1.49 1.65
Sector 1.09 17.40 1.67 2.96

VRT Directors

Name Position Start Date
Mr Lyndon Grant Hale Executive Director 17 May 2013
Ms Susan (Sue) Channon Executive Director, Chief Executive Officer 10 Apr 2008
Mr Peter John Macourt Non-Executive Chairman, Non-Executive Director 17 May 2013
Ms Sonia Petering Non-Executive Director 1 Sep 2014
Mr Greg Couttas Non-Executive Director 4 Oct 2016
Mr Shane Solomon Non-Executive Director 24 Sep 2018

VRT Management

Name Position
Glenn Powers Chief Financial Officer,Company Secretary
Anthony Walsh Executive Chairman, Ireland
Richard Banks Managing Director, Europe
Nadia Stankovic Managing Director, New South Wales
Steve Zappia Managing Director, Queensland and Virtus Health Diagnostics
Jade Phelan Managing Director, Victoria
Peter Illingworth Medical Director, New South Wales
David Moloy Medical Director, Queensland
William Watkins Medical Director, Tasmania

VRT Substantial Shareholders

Holding Name
4,681,339 (5.80%) Merlon Capital Partners Pty Ltd

VRT Calendar of Events

Date Event
18 February 2020 Report (Interim)
18 October 2019 Report (Annual)
20 August 2019 Report (Prelim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.